Apellis Pharmaceuticals
AcquiredPublic · Waltham, United States · Founded 2009 · $79.6M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 501–1000
- Founded
- 2009
- Business Model
- B2B
- Total Funding
- $79.6M
- Last Round
- $32.5M Series AFeb 2016
- Rounds
- 2
- Type
- Public
About
Global biopharmaceutical company pioneering targeted C3 therapies to treat serious complement-mediated diseases.
Summary
Apellis Pharmaceuticals is a Biotech company based in Waltham, United States, founded in 2009. It has raised $79.6M in total across 2 rounds, most recently a $32.5M Series A round in Feb 2016. Investors include Biogen.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...